STAT3: Key targets of growth-promoting receptor positive breast cancer
Abstract Breast cancer has become the malignant tumor with the first incidence and the second mortality among female cancers. Most female breast cancers belong to luminal-type breast cancer and HER2-positive breast cancer. These breast cancer cells all have different driving genes, which constantly...
Saved in:
| Main Authors: | Rui-yuan Jiang, Jia-yu Zhu, Huan-ping Zhang, Yuan Yu, Zhi-xin Dong, Huan-huan Zhou, Xiaojia Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-024-03541-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of transforming growth factor beta receptor I inhibitors on myotube formation in vitro
by: Louise De Saeytyd, et al.
Published: (2025-07-01) -
Co-Inhibition of PARP and STAT3 as a Promising Approach for Triple-Negative Breast Cancer
by: Changyou Shi, et al.
Published: (2025-07-01) -
Small molecule inhibitors targeting the cancers
by: Gui‐Hong Liu, et al.
Published: (2022-12-01) -
Interleukin-37 mediates the anti-oral tumor activity in oral cancer through STAT3
by: Fang Jing, et al.
Published: (2025-05-01) -
JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases
by: Yimeng Dai, et al.
Published: (2025-03-01)